Retinitis Pigmentosa Market Outlook to Strengthen During the Forecast Period (2026-2036) with Growing Focus on Disease-Modifying Therapies | DelveInsight
The retinitis pigmentosa market is expected to witness steady growth over the coming years, supported by increasing awareness of inherited retinal disorders, advances in genetic testing, and the development of disease-modifying therapies. The expanding clinical pipeline, including...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.